Premium
The feasibility and accuracy of sentinel lymph node biopsy in clinically node‐negative patients after neoadjuvant chemotherapy for breast cancer—a systematic review and meta‐analysis
Author(s) -
Tan Veronique K.M.,
Goh Brian K.P.,
FookChong Stephanie,
Khin LayWai,
Wong WaiKeong,
Yong WeiSean
Publication year - 2011
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.21911
Subject(s) - medicine , meta analysis , breast cancer , sentinel lymph node , chemotherapy , oncology , neoadjuvant therapy , biopsy , lymph node , radiology , cancer
The sentinel lymph node biopsy (SLNB) is now an accepted alternative to the axillary lymph node dissection for pathologic evaluation of the axilla in patients with early breast cancer. The use of SLNB after neoadjuvant chemotherapy (NAC) is controversial. This meta‐analysis aims to determine the feasibility and the accuracy of SLNB in the population of patients who are clinically node‐negative after NAC for breast cancer. J. Surg. Oncol. 2011;104:97–103. © 2011 Wiley‐Liss, Inc.